Last autumn a young man taking part in an American gene therapy trial died unexpectedly. Now the US gene therapy community and the regulators are questioning where this research should be going. Peter Evans finds out what gene therapy experiments have achieved and what the future may hold, on both sides of the Atlantic.

E-Mail: [email address removed]